Diabetes News and Research

Latest Diabetes News and Research

Genentech receives FDA approval for Vismodegib to treat skin cancer

A new skin cancer drug tested for the first time in the world five years ago at the Virginia G. Piper Cancer Center at Scottsdale Healthcare just received expedited approval by the U.S. Food and Drug Administration, a remarkable accomplishment in new drug development.

2 Feb 2012

FDA clears Roche's new test for detection of CT and NG infections

Roche announced today that the U.S. Food and Drug Administration (FDA) has provided 510(k) clearance to the cobas CT/NG Test for the detection of Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG) infections in both symptomatic and asymptomatic patients from male urine and self -collected vaginal swabs.

1 Feb 2012

First signs of atherosclerotic heart disease may appear in early childhood

When we think about people with heart disease we usually think about middle-aged men. In reality, atherosclerotic heart disease is the leading cause of death for men and women in North America, but its impact starts much earlier than adulthood. Though children will rarely, if ever, have overt symptoms of atherosclerosis, the first signs of this disease appear in early childhood and perhaps even before birth.

1 Feb 2012

Study reveals substantial differences in rates of follow-up surgeries after partial mastectomy

A new study reveals substantial differences - by both surgeon and institution - in the rates of follow-up surgeries for women who underwent a partial mastectomy for treatment of breast cancer.

1 Feb 2012

Older women who become pregnant from egg donation not at greater risk than younger counterparts

Although women over age 50 who become pregnant via egg donation are at an elevated risk for developing obstetrical complications, their complication rates are similar to those of younger recipients, according to a study by Columbia University Medical Center researchers to be published in the February 2012 issue of the American Journal of Perinatology.

1 Feb 2012

Canadian Government announces investment in personalized medicine

The Harper Government today announced an important investment that will help Canadians in getting more effective treatments and make the healthcare system more sustainable through personalized medicine.

1 Feb 2012

Decaffeinated coffee may improve brain energy metabolism linked with type 2 diabetes

Researchers from Mount Sinai School of Medicine have discovered that decaffeinated coffee may improve brain energy metabolism associated with type 2 diabetes.

1 Feb 2012

RMC first in N.J. to offer TESSYS minimally invasive surgery for patients with herniated discs

Riverview Medical Center, part of Meridian Neuroscience, today announced it is the only hospital in the state of New Jersey to offer patients the TESSYS surgery method, a minimally invasive procedure for the treatment of herniated discs.

1 Feb 2012

Majority of children can safely quit anti-rejection drugs after liver transplant from parents

Physicians at three transplant centers have found in a pilot study that a majority of children who receive liver tissue from a parent can eventually stop using immunosuppression (anti-rejection) medications safely. These drugs, which tamp down natural immune function, have been linked to a bevy of complications, including cancer, diabetes, hypertension and kidney failure.

1 Feb 2012

TGen, UA receive NFCR grant to study targeted pancreatic cancer therapies

The Translational Genomics Research Institute (TGen) and the University of Arizona (UA) have received a three-year, $600,000 grant to study targeted cancer therapies from the National Foundation for Cancer Research.

1 Feb 2012

Specific gene mutation triggers development of NAFLD

A team of scientists from the University of Utah and the University of California at San Francisco has discovered that the mutation of a gene encoding a ketone body transporter triggers accumulation of fat and other lipids in the livers of zebrafish.

1 Feb 2012

Vertex receives FDA approval for Kalydeco to treat rare form of CF

The U.S. Food and Drug Administration today approved Kalydeco (ivacaftor) for the treatment of a rare form of cystic fibrosis (CF) in patients ages 6 years and older who have the specific G551D mutation in the Cystic Fibrosis Transmembrane Regulator (CFTR) gene.

1 Feb 2012

Diet soft drink consumption may increase risk of vascular events

Individuals who drink diet soft drinks on a daily basis may be at increased risk of suffering vascular events such as stroke, heart attack, and vascular death. This is according to a new study by Hannah Gardener and her colleagues from the University of Miami Miller School of Medicine and at Columbia University Medical Center.

1 Feb 2012

Caffeine intake may change a woman’s estrogen levels: Study

The study, published in the American Journal of Clinical Nutrition, looked at more than 250 women ages 18 to 44, and found that for white women, caffeine appeared to lower estrogen levels, while in Asian women it seemed to raise them.

31 Jan 2012

Boehringer Ingelheim, Lilly receive FDA approval for Jentadueto to treat type 2 diabetes

Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company today announced the U.S. Food and Drug Administration (FDA) has approved Jentadueto (linagliptin/metformin hydrochloride) tablets, a new tablet combining the dipeptidyl peptidase-4 (DPP-4) inhibitor, linagliptin, and metformin.

31 Jan 2012

New research gains increased respect for contraceptive method

Imagine a contraceptive that could, with one or two painless 15-minute non-surgical treatments, provide months of protection from pregnancy. And imagine that the equipment needed were already in physical therapists' offices around the world.

31 Jan 2012

Bioton and Actavis form joint venture

Actavis and Bioton announced today that they have formed a joint venture company for the development and registration of insulins, including analogue insulins.

31 Jan 2012

Viewpoints: Contraceptive controversy; Revising mental health definitions

It was good news that the Obama administration withstood pressure from Roman Catholic bishops and social conservatives to deny contraceptive coverage for millions of American women who work for religiously affiliated employers. Kathleen Sebelius, the Health and Human Services secretary, rejected broad exemptions from a new rule requiring all health plans to cover birth control, without a deductible or co-payment.

31 Jan 2012

Ariz. hospitals fighting losses in political shift and in court; Ga. seeking second cancer center

A look at hospital news around the country also includes reports on a Mayo collaboration in Minnesota on immigrant health, plans for a proton cancer therapy center in South Florida and efforts by Tufts Medical Center to get a level one trauma center.

31 Jan 2012

Engineers discover electrical property in arteries

The heart's inner workings are mysterious, perhaps even more so with a new finding. Engineers at the University of Washington have discovered an electrical property in arteries not seen before in mammalian tissues.

31 Jan 2012